A biallelic loss-of-function PDIA6 variant in a second patient with polycystic kidney disease, infancy-onset

Elisa De Franco1, Matthew N Wakeling1, Russel D Frew1

  • 1Institute of Biomedical and Clinical Science, University of Exeter College of Medicine and Health, Exeter, UK.

Clinical Genetics
|July 20, 2022
PubMed

Insights

A rare genetic disorder causes severe infant health issues, including polycystic kidney disease and diabetes, linked to a PDIA6 gene defect. This study details the condition

Area of Science:

  • Genetics
  • Pediatrics
  • Endocrinology

Background:

  • Infancy-onset diabetes is a rare condition often caused by genetic factors.
  • Syndromic forms of diabetes present with multisystemic manifestations.
  • Understanding the genetic basis of rare diseases is crucial for diagnosis and management.

Observation:

  • A second patient presented with a constellation of severe congenital anomalies.
  • The patient exhibited intrauterine growth retardation, polycystic kidney disease, infancy-onset diabetes, microcephaly, and liver fibrosis.
  • Genetic analysis revealed a homozygous loss-of-function variant in the PDIA6 gene.

Findings:

  • The PDIA6 loss-of-function variant is associated with a severe syndromic form of infancy-onset diabetes.
  • This variant underlies a complex phenotype including renal, neurological, and hepatic dysfunction.
  • The study confirms and expands the clinical spectrum associated with PDIA6 deficiency.

Implications:

  • This research refines the understanding of PDIA6-related disorders.
  • Early genetic diagnosis can facilitate targeted monitoring and intervention for affected infants.
  • Further research into PDIA6 function may reveal novel therapeutic targets for related conditions.